Antidepressants and erectile dysfunction: why it happens, and what can be done about it

Antidepressants, and SSRIs in particular, are among the most common medication causes of erectile dysfunction — if it started after you began one, the medicine is a likely explanation rather than something new going wrong with you. It is also one of the more manageable causes: the published reviews describe switching to an agent with a gentler sexual side-effect profile, or adding a second medicine, and the AUA guideline on erectile dysfunction treats oral PDE5 inhibitors as a first-line option unless something contraindicates them. What you should not do is stop the antidepressant on your own. A licensed provider decides what is appropriate for you.

Why antidepressants interfere with erections

The usual explanation is pharmacological rather than psychological. SSRIs raise serotonin signalling, and serotonin tends to dampen the sexual response, so the same action that lifts mood can blunt desire, arousal and orgasm at once. That is why the problem often shows up as more than a mechanical one: men describe wanting it less, or taking longer, alongside or instead of trouble getting an erection. It is a recognised class effect, and common enough to be one of the main reasons men quietly stop a medication that was working.

Is it the antidepressant, or the depression?

Both are real, and separating them changes what to do. A 2025 literature review on antidepressant-induced sexual dysfunction makes the point directly: depression itself is often associated with sexual dysfunction, typically as reduced libido, and starting an antidepressant may ironically exacerbate it. Timing is the most useful clue you can bring to the conversation. Trouble that began within weeks of starting the medicine, or of a dose increase, points at the drug; trouble that predated it, or arrived with the low mood, points elsewhere.

Why stopping the antidepressant on your own is the wrong move

This is the most important line in this article. Stopping an antidepressant abruptly can produce discontinuation symptoms and, more seriously, risks the return of the depression or anxiety the medicine is treating — a far worse outcome than the side effect you are trying to solve. Nothing you read online, here included, is a reason to skip doses or taper by yourself. The prescriber who manages your antidepressant is the person who changes it, and sexual side effects are a standard thing to report.

The options a prescriber actually weighs

Which route is reasonable depends on how well the antidepressant is working and how long you have been on it:

• Waiting, if you started recently. Some side effects settle over the first weeks.
• Adjusting the dose. For many men the effect tracks the dose — but that is a prescriber’s adjustment, never a home experiment.
• Switching agents. The reviews name mirtazapine and vortioxetine among the antidepressants reported to carry lower rates of sexual dysfunction than SSRIs.
• Adding a second medicine. Bupropion augmentation is the most-studied adjunct in that literature.
• Treating the erectile dysfunction directly, which the AUA guideline frames as offering an oral PDE5 inhibitor unless contraindicated — an option that leaves the antidepressant alone.
• Looking past the medication. Blood pressure, diabetes, smoking, alcohol and untreated sleep problems damage the same machinery.

What treating the ED directly does, and does not, fix

A PDE5 inhibitor acts on the last step of the chain: it protects the blood-flow signal once arousal has started it. The sildenafil prescribing information is explicit that sexual stimulation is required for it to do anything at all. That matters here more than in most cases, because the complaint an SSRI produces is frequently upstream — desire has gone flat, not the plumbing. A blood-flow medicine addresses the half of the problem it can reach, and nobody should tell you otherwise. Some compounded formulas add a centrally acting ingredient for that reason; whether any of it suits you is a clinical judgement.

What a provider checks before prescribing anything

• Nitrates in any form — nitroglycerin, isosorbide, or recreational “poppers.” The PDE5 labels list these as a contraindication, not a caution to weigh.
• Your full medication list, the antidepressant included, plus anything prescribed by someone else.
• Alpha blockers and blood-pressure medicines, where the labels warn about symptomatic low blood pressure when the effects stack.
• Cardiac history, which the AUA guideline treats partly as whether you are well enough for sexual activity.
• Your mental-health history, because the answer is sometimes a conversation with your psychiatric prescriber rather than a new prescription.

How Ignite works

Ignite by StaveMD is a compounded sublingual preparation with four actives — sildenafil, tadalafil, L-citrulline and apomorphine — filled by a licensed compounding pharmacy. It is not FDA-approved as a finished product, and it does not treat depression or replace anything your psychiatric prescriber manages: it is one preparation a licensed provider may consider when they judge it appropriate for you. The private intake takes about three minutes and asks for every medication you take, including antidepressants, because that is what the provider reviews before deciding; if they decide it is not a fit, nothing is shipped and you are refunded in full. It is $129, one flat price with no membership fee, for adults 21 and over. Individual results vary.